{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial on the Safety of General Anesthesia in Pediatric Adenotonsillectomy"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "Conducted as a randomised controlled trial in a tertiary care setting"
      },
      "Participants": {
        "score": 2,
        "evidence": "children under 15 years old undergoing adenotonsillectomy. Eligibility criteria emphasized obstructive sleep apnea and other comorbidities"
      },
      "Intervention": {
        "score": 2,
        "evidence": "the intervention group received a specific anesthetic protocol, while the control group received standard care"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the safety of general anesthesia in adenotonsillectomy"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the incidence of perioperative respiratory events, assessed over a 24-hour postoperative period"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was achieved using a computer-generated sequence, with allocation concealment via sealed envelopes"
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded to group assignments"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised, with 100 in each group, recruited between January 2020 and June 2021"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted on 98 participants in the intervention group and 97 in the control group using an intention-to-treat approach"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The intervention group experienced a significant reduction in respiratory events compared to the control group (mean difference = 5.2 events, 95% CI 3.1 to 7.3; p = 0.01)"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events occurred in 3% of the intervention group and 1% of the control group, with mild severity"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 21,
    "max_score": 25
  },
  "model": "gpt-4o"
}